Skip to content

Palmar-Plantar Erythrodysesthesia

Last updated: 29 May 2024
1/2
  1. Palmar-Plantar Erythrodysesthesia
  2. Palmer Plantar Grading Scale PPE (adapted NCI CTCAE)
Palmar-Plantar Erythrodysesthesia

Palmar-Plantar Erythrodysesthesia

Palmar-Plantar Erythrodysesthesia (PPE) is a dermatologic toxicity associated with a number of chemotherapeutic drugs and some kinase inhibitors. Also known as Hand-Foot Syndrome (HFS), it is characterised by tingling and tenderness developing to symmetrical redness, swelling, and pain primarily on the palm of the hand and sole of the foot.

Palmar-plantar erythrodysesthesia associated with chemotherapy and its treatment by K. P. Farr and A. Safwat is licensed under CC BY-NC-ND 3.0.
View larger
View larger

Palmer Plantar Grading Scale PPE (adapted NCI CTCAE)

Grade 1

(Mild)

Grade 2

(Moderate)

Grade 3

(Severe)

Minimal skin changes or dermatitis (e.g.

erythema, oedema, or

hyperkeratosis) without pain

Skin changes (e.g.

peeling, blisters,

bleeding, oedema, or

hyperkeratosis) with

pain; limiting self-care

activities of daily living (ADLs)

Severe skin changes (e.g. peeling, blisters, bleeding, oedema, or

hyperkeratosis) with

pain; limiting self-care

ADLs

Grade 1 (Mild) – Non Urgent

Patient Management

● Prevention, support, teaching, & follow-up as required

● Skin Care

- Before any symptoms develop liberal use of NON-urea based creams regularly to soften the skin.

Avoid alcohol-based products.

Skin care considerations:

- Avoid sun exposure during treatment – use sun block

- Avoid contact with harsh chemicals – use non - rubberised protective gloves.

- Avoid using hands for activities that might cause abrasion.

- Avoid exposure to hot water. Clean hands, feet with lukewarm water and gently pat dry.

- Promote adequate hydration/nutrition during treatment to help prevent skin dryness or

desquamation.

Pharmacological Management

- Collaborate with clinician / team.

- Pharmacological management (e.g. topical application of emollient urea 10%).

● Patient Education and Follow-Up

- Encourage daily self-assessment of skin

- Early signs of PPE – tingling and numbness, areas of dry furrowed skin with any changes in

pigmentation.

- When to seek immediate medical attention:

- Temperature greater than or equal to 38°C and/or presence of redness, discharge or odour from open areas

- When unable to perform ADLs

  • When pain is not controlled.

Grade 2 (Moderate) - Urgent

● Requires medical attention within 24 hours

● Collaborate with clinician / team

- Treatment delays, reductions or discontinuation of treatment.

- Management of skin complications

- Pharmacological management (e.g. pain management – topical or oral, antibiotics if infection

Identified).

- Patient education and follow-up (as previous step)

Grade 3 (Severe) - Emergency

● Requires IMMEDIATE medical attention

Patients will generally require hospital admission

Notify clinician / team of ABC CNS assessment

Notify Emergency Department

Was this article helpful?

Suggest an edit

Suggest an edit

Would additional content be helpful on this page? Email suggestions and feedback to intouch@bcf.org.nz. Thank you.

This field is optional
(e.g.+6421 000 0000)